Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

BNKL

Bionik Laboratories Corp.

USD

Set alert

Price alert · BNKL

All alert types
0.00 USD 0.00 0.00%
As of Oct 29, 2026
0.0001 Day range 0.0001
0.0001 52-week range 0.0001
YTD
0.00%
1 year
0.00%
Open
0.0001
Prev close
0.0001
Mkt cap
1.25K
Vol
578
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.0001
High
0.0001
Earnings
Jul 3, 2024

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for BNKL has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-45.83 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.6×
FY 2013: -13469×FY 2014: -5978×FY 2016: 69.1×FY 2017: -9.6×FY 2018: -0.5×FY 2019: -1.0×FY 2020: -0.3×FY 2021: -0.9×FY 2022: -0.2×FY 2023: -0.6×
FY 2013 5y median -0.6× FY 2023
P/S 1.5×
FY 2013: 33965×FY 2014: 29436×FY 2016: 0.0×FY 2017: 65.8×FY 2018: 7.4×FY 2019: 3.1×FY 2020: 3.8×FY 2021: 10.7×FY 2022: 1.7×FY 2023: 1.5×
FY 2013 5y median 3.1× FY 2023
P/B -1.7×
FY 2013: -18004×FY 2014: -4490×FY 2016: 271×FY 2017: 1.6×FY 2018: 0.4×FY 2019: 0.4×FY 2020: 0.6×FY 2021: 3.9×FY 2022: 0.7×FY 2023: -1.7×
FY 2013 5y median 0.6× FY 2023
P/FCF -0.8×
FY 2013: -12090×FY 2014: -13266×FY 2016: -14.9×FY 2017: -5.3×FY 2018: -0.9×FY 2019: -1.1×FY 2020: -0.9×FY 2021: -2.8×FY 2022: -0.5×FY 2023: -0.8×
FY 2013 5y median -0.9× FY 2023
EV/EBITDA -1.0×
FY 2013: -13473×FY 2014: 36028×FY 2016: -10.1×FY 2017: -5.4×FY 2018: -0.7×FY 2019: -1.4×FY 2020: -0.3×FY 2021: -1.2×FY 2022: -0.0×FY 2023: -1.0×
FY 2013 5y median -1.0× FY 2023
EV/Sales 2.6×
FY 2013: 33964×FY 2014: 29609×FY 2016: 0.0×FY 2017: 69.4×FY 2018: 6.9×FY 2019: 3.0×FY 2020: 3.7×FY 2021: 13.3×FY 2022: 0.2×FY 2023: 2.6×
FY 2013 5y median 3.0× FY 2023
FCF Yield -122.7%
FY 2013: -0.0%FY 2014: -0.0%FY 2016: -6.7%FY 2017: -19.0%FY 2018: -106.4%FY 2019: -92.9%FY 2020: -111.9%FY 2021: -36.1%FY 2022: -189.8%FY 2023: -122.7%
FY 2013 5y median -111.9% FY 2023

Profitability

Gross Margin 54.8%
FY 2013: 100.0%FY 2014: -16.7%FY 2016: 0.0%FY 2017: 32.0%FY 2018: 59.2%FY 2019: 49.8%FY 2020: 58.5%FY 2021: 77.4%FY 2022: 74.8%FY 2023: 54.8%
FY 2013 5y median 58.5% FY 2023
Operating Margin -267.3%
FY 2013: -252.1%FY 2014: -492.1%FY 2016: 0.0%FY 2017: -1390.7%FY 2018: -1016.6%FY 2019: -224.6%FY 2020: -522.2%FY 2021: -515.8%FY 2022: -374.7%FY 2023: -267.3%
FY 2013 5y median -374.7% FY 2023
Net Margin -274.0%
FY 2013: -252.1%FY 2014: -492.1%FY 2016: 0.0%FY 2017: -688.3%FY 2018: -1491.6%FY 2019: -325.2%FY 2020: -1157.9%FY 2021: -1141.3%FY 2022: -817.1%FY 2023: -274.0%
FY 2013 5y median -817.1% FY 2023
ROE 301.5%
FY 2013: 133.6%FY 2014: 75.1%FY 2016: 392.6%FY 2017: -17.0%FY 2018: -72.0%FY 2019: -38.5%FY 2020: -187.2%FY 2021: -415.1%FY 2022: -355.6%FY 2023: 301.5%
FY 2013 5y median -187.2% FY 2023
ROIC -448.8%
FY 2013: 133.6%FY 2014: -76.5%FY 2016: -2513.4%FY 2017: 1.0%FY 2018: -48.9%FY 2019: -26.6%FY 2020: -73.0%FY 2021: -84.3%FY 2022: -149.9%FY 2023: -448.8%
FY 2013 5y median -84.3% FY 2023
ROA -147.1%
FY 2013: -296.4%FY 2014: -910.8%FY 2016: 16.6%FY 2017: -13.6%FY 2018: -51.5%FY 2019: -34.4%FY 2020: -134.7%FY 2021: -155.0%FY 2022: -222.6%FY 2023: -147.1%
FY 2013 5y median -147.1% FY 2023

Growth (YoY)

Revenue 41.7%
FY 2013: -30.7%FY 2014: 15.4%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 72.6%FY 2019: 228.7%FY 2020: -33.7%FY 2021: -44.6%FY 2022: 6.7%FY 2023: 41.7%
FY 2013 FY 2023
Operating Income -1.1%
FY 2013: -45.6%FY 2014: -125.2%FY 2016: 0.0%FY 2017: -19.9%FY 2018: -26.2%FY 2019: 27.4%FY 2020: -54.3%FY 2021: 45.3%FY 2022: 22.5%FY 2023: -1.1%
FY 2013 FY 2023
EPS (diluted) 59.6%
FY 2013: -64.4%FY 2014: -125.3%FY 2016: 0.0%FY 2017: -431.4%FY 2018: -240.3%FY 2019: 79.6%FY 2020: -25.3%FY 2021: 52.5%FY 2022: 33.1%FY 2023: 59.6%
FY 2013 FY 2023
Free Cash Flow 18.6%
FY 2013: -80.9%FY 2014: 8.9%FY 2016: 0.0%FY 2017: -49.5%FY 2018: -7.9%FY 2019: -20.7%FY 2020: 1.2%FY 2021: 49.9%FY 2022: 10.0%FY 2023: 18.6%
FY 2013 FY 2023

Financial Health

Current Ratio 1.2×
FY 2013: 0.3×FY 2014: 0.1×FY 2016: 1.0×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 1.1×FY 2020: 1.1×FY 2021: 0.8×FY 2022: 3.1×FY 2023: 1.2×
FY 2013 5y median 1.1× FY 2023
Quick Ratio 0.8×
FY 2013: 0.3×FY 2014: 0.1×FY 2016: 1.0×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 1.0×FY 2020: 0.9×FY 2021: 0.7×FY 2022: 2.3×FY 2023: 0.8×
FY 2013 5y median 0.9× FY 2023
Debt / Equity -1.5×
FY 2013: 0.0×FY 2014: -26.5×FY 2016: 0.0×FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 1.1×FY 2022: 0.0×FY 2023: -1.5×
FY 2013 5y median 0.0× FY 2023
Net Debt / EBITDA -0.4×
FY 2013: 0.3×FY 2014: 210×FY 2016: 0.8×FY 2017: -0.3×FY 2018: 0.0×FY 2019: 0.1×FY 2020: 0.0×FY 2021: -0.2×FY 2022: 0.2×FY 2023: -0.4×
FY 2013 5y median 0.0× FY 2023
Interest Coverage -45.0×
FY 2013: 0.0×FY 2014: 0.0×FY 2016: -2336×FY 2017: -182×FY 2018: -2.2×FY 2019: -2.2×FY 2020: -61.8×FY 2021: -15.2×FY 2022: -5.8×FY 2023: -45.0×
FY 2013 5y median -15.2× FY 2023

Dividends

Dividend Yield 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2013 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2013: 0.0%FY 2014: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2013 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-03-31